Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.9135 | 38 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.89224 | 39 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.89587 | 39 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.84016 | 39 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.80747 | 37 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.94962 | 38 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.96125 | 39 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.86845 | 38 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.87458 | 39 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.87874 | 39 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.87764 | 39 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.86491 | 39 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.8872 | 39 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.88568 | 39 |